Liberum Capital Reiterates Hold Rating for Victrex (LON:VCT)
Liberum Capital reissued their hold rating on shares of Victrex (LON:VCT) in a research report released on Friday morning, ThisIsMoney.Co.Uk reports.
VCT has been the subject of a number of other reports. Barclays lowered their price objective on shares of Victrex from GBX 1,690 ($20.80) to GBX 1,660 ($20.43) and set an underweight rating for the company in a research note on Wednesday, June 24th. Jefferies Financial Group upgraded shares of Victrex to a buy rating and reduced their target price for the stock from GBX 2,320 ($28.55) to GBX 2,200 ($27.07) in a report on Tuesday, May 19th. Credit Suisse Group reiterated an outperform rating on shares of Victrex in a report on Friday. Peel Hunt reiterated a hold rating on shares of Victrex in a report on Thursday, June 11th. Finally, Berenberg Bank cut their price objective on shares of Victrex from GBX 2,200 ($27.07) to GBX 2,000 ($24.61) and set a hold rating on the stock in a report on Monday, April 6th. Four research analysts have rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the stock. The company has an average rating of Hold and a consensus price target of GBX 1,994.09 ($24.54).
VCT stock opened at GBX 1,990 ($24.49) on Friday. The stock has a market capitalization of $1.73 billion and a price-to-earnings ratio of 19.40. Victrex has a twelve month low of GBX 1,645 ($20.24) and a twelve month high of GBX 2,574 ($31.68). The company has a quick ratio of 2.36, a current ratio of 4.40 and a debt-to-equity ratio of 1.72. The firm’s fifty day simple moving average is GBX 2,008.80 and its two-hundred day simple moving average is GBX 2,164.77.
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, ortho, dental, trauma, knee, cardiovascular, and orthopedic applications. It also offers specialist solutions for medical device manufacturers.
See Also: What is a Stop Order?
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.